InterMune seeks FDA marketing approval for pirfenidone

Download PDF Copy

Reviewed

InterMune, Inc.Nov 5 2009

InterMune, Inc. (Nasdaq: ITMN) today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.

"IPF is a rapidly and uniformly fatal disease. Sadly, there are no medicines approved for the approximately 100,000 Americans who suffer from this terrible disease," said Dan Welch, Chairman, Chief Executive Officer and President of InterMune. "InterMune has dedicated almost ten years to the development of new medicines for patients with IPF. We are very proud to have submitted the first NDA ever submitted to the FDA for a medicine to treat IPF patients."

Source:

InterMune, Inc.

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anti-Inflammatory, Biotechnology, Cough, Dyspnea, Fibrosis, Food, Hepatitis C, Hepatology, Idiopathic Pulmonary Fibrosis, Medicine, New Drug Application, Pirfenidone, Pulmonary Fibrosis, Toxicology, Virus

Comments (1)

Download PDF Copy

Suggested Reading

Limiting fast-food outlets can reduce childhood overweight and obesity

Living in food deserts during early childhood raises long-term obesity risk

Key triggers for food allergies in children after organ transplants

Study finds thousands of food-contact chemicals in humans, raising safety concerns

High levels of microplastics found in prostate tumors, possibly linked to take-out food

Updated Food Compass 2.0 improves food health ratings using new diet data

Ultra-processed food linked to weight gain and lower well-being in adolescents

Social media normalizes unhealthy food choices, shaping youth habits and brand loyalty

Comments

Beware of Photo-Sensitivity Issue

Sandie says:

November 7, 2009 at 8:14 PM

Be aware the quality of life may be greatly affected by the photo-sensitivity you will have while taking this medication. Any exposure to sun causes a painful - uncomfortable skin like condition similar to a sunburn. You will have to be entirely covered - including extremeties while outside.

0 0

Reply